NCT04431856

Brief Summary

The purpose of this research study is to collect information to better understand caregiver responses to COVID-19 stress and to help caregivers cope with these stressors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2020

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

June 12, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2020

Completed
Last Updated

December 1, 2020

Status Verified

November 1, 2020

Enrollment Period

6 months

First QC Date

June 12, 2020

Last Update Submit

November 30, 2020

Conditions

Keywords

COVID-19

Outcome Measures

Primary Outcomes (3)

  • Measure of Anxiety as assessed by the OASIS

    The Overall Anxiety Severity and Impairment Scale (OASIS) is a 5 self-reported questionnaire evaluating the severity and functional impairment due to anxiety. The total score ranges from 0 (no anxiety) to 20 (severe anxiety).

    week 6 and week 12

  • Measure of Depression as assessed by the ODSIS

    Overall Depression Severity and Impairment Scale (ODSIS) is a 5-item measure assessing the frequency and intensity of depressive symptoms. The total score ranges from 0-20 with the higher score indicating increased depression.

    week 6 and week 12

  • Measure of PTSD as assessed by the PCL-5

    PTSD Checklist (PCL-5) is a 20-item measure of PTSD symptoms in adults. Total score ranges from 0 to 80 with the higher score indicating higher PTSD symptoms.

    week 6 and week 12

Secondary Outcomes (4)

  • Measure of Parenting Overprotection/Overcontrol as assessed by the S-EMBU

    week 6 and week 12

  • Measure of Parenting Rejection as assessed by the S-EMBU

    week 6 and week 12

  • Measure of Parenting Emotional Warmth as assessed by the S-EMBU

    week 6 and week 12

  • Measure of Parent Accommodation for Child Anxiety as assessed by the FASA

    week 6 and week 12

Study Arms (2)

Immediate Condition

EXPERIMENTAL

Participants in the Immediate Condition group will receive a total of 4 sessions of Unified Protocol for COVID-19 Parenting Stress (UP-COVID) intervention

Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)

Delayed Condition

ACTIVE COMPARATOR

Participants in the Delayed Condition group will receive the Self Help Guide (SHG) by the National Child Traumatic Stress Network (NCTSN). They will then receive the UP-COVID intervention following their week 6 assessment

Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)Behavioral: SHG

Interventions

UP-COVID is a group therapy session with each session lasting approximately 60-90 minutes. The sessions will focus on cognitive and behavioral strategies for managing their own distress, anxiety and sadness related to COVID-19, as well as, strategies related to parenting in the midst of the crisis.

Delayed ConditionImmediate Condition
SHGBEHAVIORAL

Brochure that details techniques for coping with stress.

Delayed Condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • consent to participate via RedCap
  • indicate a mild or greater elevation on screening measures of anxiety, depression and/or traumatic stress
  • have a child between 6 and 13 years
  • speak/read English or Spanish fluently

You may not qualify if:

  • reported severe mental illness (e.g., bipolar disorder, schizophrenia, an intellectual disability, psychosis, alcohol use disorder, substance use disorder) or hospitalization for mental health concerns or suicide attempt.
  • reported prior arrest for child endangerment, child abuse or child neglect, or prior investigation by the Florida Department of Children and Families (DCF)
  • may be excluded if the severity of current mental illness is such that outpatient, weekly group treatment would be considered inappropriate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33146, United States

Location

MeSH Terms

Conditions

Anxiety DisordersDepressionStress Disorders, TraumaticCOVID-19

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorTrauma and Stressor Related DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Jill Ehrenreich-May, Ph.D.

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 12, 2020

First Posted

June 16, 2020

Study Start

May 15, 2020

Primary Completion

November 17, 2020

Study Completion

November 17, 2020

Last Updated

December 1, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations